Skip to main content

Table 2 Comorbidity disease and CCI score

From: Correlation between the Charlson comorbidity index and skeletal muscle mass/physical performance in hospitalized older people potentially suffering from sarcopenia

 

All(n = 168)

Men(n = 99)

Women(n = 69)

Comorbidity disease, n (%)

 MI

22 (13.10)

13 (13.13)

9 (13.04)

 CHD

20 (11.90)

17 (17.17)

3 (4.35)

 PAOD

6 (3.57)

3 (3.03)

3 (4.35)

 CVD

98 (58.33)

68 (68.69)

30 (43.48)

 SD

11 (6.55)

2 (2.02)

9 (13.04)

 COPD

20 (11.90)

11 (11.11)

9 (13.04)

 CTD

6 (3.57)

0 (0)

6 (8.70)

 GU

49 (29.17)

31 (31.31)

18 (26.09)

 DM

65 (38.69)

50 (50.51)

15 (21.74)

 CKD

22 (13.10)

13 (13.13)

9 (13.04)

 HP

2 (1.19)

2 (2.02)

0 (0)

 CL

0 (0)

0 (0)

0 (0)

 ML

1 (0.60)

1 (1.01)

0 (0)

 tumor

49 (29.17)

28 (28.28)

21 (30.43)

 LD

14 (8.33)

11 (11.11)

3 (4.35)

CCI score, n (%)

 4

11 (6.55)

4

7

 5

33 (19.64)

7

26

 6

54 (32.14)

33

21

 7

24 (14.29)

21

3

 8

22 (13.10)

22

0

 9

7 (4.17)

4

3

 10

3 (1.79)

3

0

 11

5 (2.98)

2

3

 12

8 (4.76)

2

6

 13

1 (0.60)

1

0

  1. MI Miocardial infarction, CHD Chronic heart failure, PAOD Peripheral arterial obstructive disease, CVD Cerebral vascular disease, SD Senile dementia, COPD Chronic obstructive pulmonary disease, CTD Connective tissue disease, GU Gastroduodenal ulcer, DM Diabetes mellitus, CKD Chronic kidney disease, HP Hemiplegic paralysis, CL Chronic leukemia, ML malignant lymphadenoma, LD Liver disease